“In 2017, Ramaswamy partnered with CITIC Group, a state-owned Chinese investment firm, to form a company called Sinovant, focused on “bringing innovative medicines to China and advancing Chinese biopharmaceutical innovation abroad.”
Discussion
No replies yet.